Find the Perfect Plan for Your Investment Journey
L
Last Price
52 Week Range
HK$2.16 - HK$6.50
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | HK$7.87B |
EV | HK$8.24B |
Shares Outstanding | 1.71B |
Beta | -0.14 |
Analyst Rating | HOLD |
Analyst Target Price | HK$4.69 |
P/E 2025E | - |
P/Revenue 2025E | 19.49x |
Revenue | - |
EPS | 28.50% |
Operating Cash Flow | 31.90% |
Free Cash Flow | 30.60% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | -61.76% |
ROCE 2024 | -51.43% |
DPS 2025E | HK$0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
L
Lepu Biopharma Co., Ltd.
2157
Sector
Healthcare
Industry
Biotechnology
CEO
Sui, Ziye
Employees
498
Website
www.lepubiopharma.comIPO Date
2022-02-23
Headquarters
No. 651, Lianheng Road, Minhang District, Shanghai 201612, China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved